Press Release: European Medicines Agency to push ahead in 2014 towards publication and access to clinical trial data

The European Medicines Agency (EMA), announced on 17 December 2013, that ith had reviewed all comments received on its draft policy on publication and access to clinical trial data. While the comments received showed that there was large support for the Agency’s plans to allow access to clinical trial data submitted as part of marketing authorisation applications, they also highlighted that there was a need for further analysis and clarification of certain aspects.

The Agency stated that it had embarked on developing its plans for the proactive publication and access to clinical-trial data because it believed that the release of data was about establishing trust and confidence. The Agency was also firmly of the opinion that wider availability of data broadened the scientific knowledge base, fostered innovation and encouraged investment in the development of medicines and ultimately benefited public health.

• Primary Source

ESO: Background information: Ending drug trial secrecy is a boon for R&D, says EU agency http://www.europeansources.info/record/ending-drug-trial-secrecy-is-a-boon-for-rd-says-eu-agency/

---